hear a lot about pharmacogenetics

June 1999

You're going to hear a lot about pharmacogenetics...how an individual's genetic profile affects their response to drugs.

For example, one in 14 Caucasian patients doesn't benefit from codeine...because they lack the gene for the enzyme that converts codeine to its active metabolite, morphine.

A genetic test is used to identify breast cancer patients who might benefit from Herceptin...because it only works for tumors that overproduce the HER2 protein.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote